ADRA1B Antikörper (C-Term, Cytoplasmic Domain)
Kurzübersicht für ADRA1B Antikörper (C-Term, Cytoplasmic Domain) (ABIN1731575)
Target
Alle ADRA1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term, Cytoplasmic Domain
-
Spezifität
- Reacts with human ADRA1B
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 20 amino acid peptide from C-terminal cytoplasmic domain of human ADRA1B. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Monkey (95%), Marmoset (95%), Mouse (85%), Hamster (85%), Elephant (85%).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: ELISA, IHC - P (10 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Andere Bezeichnung
- ADRA1B
-
Hintergrund
- This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes
-
UniProt
- P35368
-
Pathways
- AMPK Signaling, Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Target
-